drugset / Trial / NCT00932828
Determining the Efficacy and Value of Immunotherapy on the Likelihood of Peanut Tolerance: The DEVIL Study
NaSingle-groupOpen-labelTreatment
Summary
Peanut allergy is known to cause severe anaphylactic reactions.The goal of this proposal is to produce a new treatment that would benefit young subjects who have recently been diagnosed with peanut allergy by lowering the risk of anaphylactic reactions (desensitization), and changing the peanut-specific immune response in subjects who have peanut allergy (tolerance).
Timeline
- Start
- 2009-06-22
- Primary completion
- 2017-02-01
- Completion
- 2017-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Defatted peanut | Unknown | 300 mg | Oral |
| Subject | Defatted peanut | Unknown | 3000 mg | Oral |